Status:
COMPLETED
Study of Acid Peel and Laser for the Treatment of Melasma
Lead Sponsor:
Northwestern University
Conditions:
Melasma
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The objective of this study is to evaluate laser treatment and acid peel for the treatment of melasma.
Detailed Description
The purpose of this study is to evaluate the safety and efficacy of laser treatment and acid peel for the treatment of melasma.
Eligibility Criteria
Inclusion
- Diagnosis of melasma lesion measuring at least 4 square centimeters.
- Age 18-75 years.
- Good health.
- Willingness and ability to understand and provide informed consent for participation in the study.
- Ability to communicate with the investigator.
- Must be willing to forgo other treatment options for melasma during the course of the study.
Exclusion
- Inability to understand the protocol or to give informed consent.
- Mental illness.
- Under 18 years of age and over 75 years of age.
- Laser treatment in the last 6 months before enrollment.
- Isotretinoin within the past year.
- Lidocaine allergy.
- History of herpes simplex viral infection.
- Concurrent active disease to facial area (i.e acne).
- Bleeding disorder.
- History of abnormal wound healing.
- History of abnormal scarring.
Key Trial Info
Start Date :
May 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00467233
Start Date
May 1 2007
End Date
June 1 2009
Last Update
December 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern University Feinberg School of Medicine, Department of Dermatology
Chicago, Illinois, United States, 60611